Ibuprofen Kruidvat (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, it reduces pain signaling, lowers the hypothalamic set‑point for temperature, and limits the inflammatory response.

The appropriate dose of Ibuprofen Kruidvat is determined by a qualified prescriber or pharmacist based on the individual's age, weight, clinical condition, and response to therapy. Patients should follow the specific instructions provided on the product label or by their healthcare professional.

Safety of ibuprofen in pregnancy and lactation is not fully established. It is generally advised to avoid ibuprofen during the third trimester and to consult a healthcare professional before use in any trimester or while breastfeeding to weigh potential risks and benefits.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuprofen shares a similar mechanism of action with other non‑selective NSAIDs such as naproxen and diclofenac, but it generally has a shorter half‑life, which may allow for more flexible dosing. Its safety profile is comparable, though individual tolerability and specific risk factors (e.g., cardiovascular or gastrointestinal) influence drug choice.

Ibuprofen Kruidvat should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and keep out of reach of children.

The product is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce the likelihood of gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, and increased cardiovascular events (e.g., heart attack or stroke) especially with high‑dose or prolonged therapy. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, blood in stools, sudden swelling, or difficulty breathing.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or advanced renal disease should avoid using ibuprofen. It is also contraindicated in the third trimester of pregnancy and should be used with caution in the first two trimesters after medical advice.